Walleye Capital LLC Abbott Laboratories Put Options Transaction History

Walleye Capital LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $1.79 Million - $2.11 Million	17,900 Added 16.74%	124,800 $14.2 Million
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $2.19 Million - $2.44 Million	-21,700 Reduced 16.87%	106,900 $11.1 Million
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $941,872 - $1.04 Million	8,600 Added 7.17%	128,600 $14.6 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $4.68 Million - $5.73 Million	51,900 Added 76.21%	120,000 $13.2 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $3.74 Million - $4.48 Million	39,100 Added 134.83%	68,100 $6.6 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $1.14 Million - $1.27 Million	11,300 Added 63.84%	29,000 $3.16 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $1.7 Million - $2.01 Million	17,600 Added 17600.0%	17,700 $1.79 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $9,506 - $11,152	100 New	100 $10,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.